## Clinical Presentation Analysis This patient presents with features strongly suggesting **renal artery stenosis (RAS)** as the secondary cause of hypertension. ### Key Clinical Clues | Finding | Significance | |---------|---------------| | **Worsening hypertension despite antihypertensive therapy** | Suggests secondary, treatment-resistant hypertension | | **Acute rise in creatinine** (1.0 → 2.2 mg/dL) | Indicates progressive renal hypoperfusion — hallmark of RAS | | **Pulsatile abdominal mass / 5.5 cm infrarenal AAA** | Atherosclerotic disease — same process causes RAS | | **Dyspnea and fatigue** | Consequences of poorly controlled hypertension and renal dysfunction | | **Age 42, male, established hypertension** | Atherosclerotic RAS is the most common secondary cause in this demographic | ## Why Renal Artery Stenosis? **Key Point:** Atherosclerotic renal artery stenosis (ARAS) is the most common secondary cause of hypertension in patients over 40 years of age. The same atherosclerotic process that produces an infrarenal AAA frequently involves the renal arteries, causing progressive renal ischemia and RAAS-mediated hypertension (Harrison's Principles of Internal Medicine, 21st ed., Chapter on Renovascular Hypertension). ### Mechanism Renal artery stenosis → reduced renal perfusion pressure → juxtaglomerular apparatus releases renin → angiotensin II elevation → aldosterone release → sodium retention + vasoconstriction → hypertension + progressive renal dysfunction. ### Regarding the Renin/Aldosterone Values The serum aldosterone of 18 ng/dL and plasma renin activity of 2.1 ng/mL/h are described as "normal range," but these values must be interpreted in context: - In bilateral RAS or RAS in a solitary functioning kidney, renin may be suppressed on the contralateral side, yielding a "normal" peripheral PRA despite active renovascular hypertension. - The **acute doubling of creatinine** is the most clinically compelling indicator of renal hypoperfusion, and in the context of documented atherosclerotic disease (AAA), RAS is the leading diagnosis. - Normal peripheral renin does NOT exclude RAS — this is a well-recognized limitation (Kaplan's Clinical Hypertension). ## Differential Diagnosis Exclusion ### Aortic Aneurysm with Aortic Regurgitation (Option B) - An **infrarenal** AAA does not cause aortic regurgitation; AR arises from **aortic root** dilatation (ascending aorta), not infrarenal disease. - There is no mention of wide pulse pressure, diastolic murmur, or echocardiographic evidence of AR in this vignette. - AAA itself is not a recognized secondary cause of hypertension. ### Fibromuscular Dysplasia (Option A) - FMD typically affects **young women** (<40 years), causing renal artery stenosis with a "string-of-beads" appearance. - A 42-year-old male with atherosclerotic AAA is not the typical FMD demographic. ### Aortic Coarctation (Option C) - Presents in **childhood/young adulthood** with upper-extremity hypertension, radio-femoral delay, and rib notching on imaging. - Does not explain an infrarenal AAA or acute renal dysfunction. ## High-Yield Summary **High-Yield:** In a middle-aged male with atherosclerotic AAA, worsening hypertension, and acute-on-chronic renal dysfunction, **renal artery stenosis** (atherosclerotic) is the most likely secondary cause of hypertension. The co-existence of AAA and RAS reflects the systemic nature of atherosclerosis. Diagnosis is confirmed by CT angiography or duplex Doppler of the renal arteries. ## Management Priorities 1. **CT angiography / duplex Doppler** of renal arteries to confirm RAS 2. **ACE inhibitor or ARB** (with close creatinine monitoring) for RAAS blockade 3. **Vascular surgery consultation** for AAA (>5 cm, high rupture risk) 4. **Aggressive atherosclerosis risk factor modification** (statin, antiplatelet therapy) 5. **Renal revascularization** (percutaneous transluminal angioplasty ± stenting) if renal function continues to deteriorate
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.